Legend Biotech Corporation (LEGN)

Legend Biotech Stock Forecast

Stock Price Forecast

The 12 analysts that cover Legend Biotech stock have a consensus rating of "Strong Buy" and an average price target of $69.58, which forecasts a 202.79% increase in the stock price over the next year. The lowest target is $48 and the highest is $90.

Price Target: $69.58 (+202.79%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$48	$69.58	$74	$90
Change	+108.88%	+202.79%	+222.02%	+291.64%

Analyst Ratings

The average analyst rating for Legend Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	4	4	4	4	4
Buy	6	7	7	7	8	8
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	12	12	12	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Eric Schmidt Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $75 → $74	Buy	Maintains	$75 → $74	+222.02%	Dec 17, 2025
Matthew Harrison Morgan Stanley	Morgan Stanley	Buy Maintains $83 → $50	Buy	Maintains	$83 → $50	+117.58%	Dec 12, 2025
Ashwani Verma UBS	UBS	Strong Buy Maintains $54 → $48	Strong Buy	Maintains	$54 → $48	+108.88%	Dec 8, 2025
Gena Wang Barclays	Barclays	Buy Maintains $94 → $90	Buy	Maintains	$94 → $90	+291.64%	Nov 13, 2025
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $75 → $74	Buy	Maintains	$75 → $74	+222.02%	Nov 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.06B

Increased by 68.83%

from 627.24M

Revenue Next Year

1.60B

Increased by 51.27%

from 1.06B

EPS This Year

-0.95

from -0.97

EPS Next Year

0.47

from -0.95

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	75.00M	68.83M	117.01M	285.14M	627.24M	1.06B	1.60B
Revenue Growth	21.36%	-8.23%	70.00%	143.70%	119.97%	68.83%	51.27%
EPS	-2.26	-2.87	-2.81	-2.94	-0.97	-0.95	0.47
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	48.90
No. Analysts	-	-	-	-	-	20	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	1.1B	2.0B
Avg	1.1B	1.6B
Low	991.6M	1.3B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	82.5%	89.7%
Avg	68.8%	51.3%
Low	58.1%	27.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.70	1.04
Avg	-0.95	0.47
Low	-1.56	0.16

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.